LivaNova issues notice to U.S. patients regarding cybersecurity incident
Seeking Alpha News (Thu, 25-Apr 4:07 PM ET)
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
Business Wire (Thu, 25-Apr 4:03 PM ET)
LivaNova to Announce First-Quarter 2024 Results
Business Wire (Thu, 21-Mar 9:00 AM ET)
Business Wire (Wed, 20-Mar 9:00 AM ET)
EDM Media (Tue, 5-Mar 10:36 PM ET)
Business Wire (Tue, 5-Mar 9:55 PM ET)
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
Business Wire (Mon, 4-Mar 4:44 PM ET)
LivaNova to Present at the Barclays Global Healthcare Conference
Business Wire (Mon, 4-Mar 9:00 AM ET)
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
Business Wire (Wed, 21-Feb 6:00 AM ET)
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
Livanova PLC - trades on the NASDAQ stock market under the symbol LIVN.
As of April 26, 2024, LIVN stock price climbed to $55.53 with 522,701 million shares trading.
LIVN has a beta of 1.28, meaning it tends to be more sensitive to market movements. LIVN has a correlation of 0.17 to the broad based SPY ETF.
LIVN has a market cap of $2.99 billion. This is considered a Mid Cap stock.
Last quarter Livanova PLC - reported $310 million in Revenue and $.87 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.10.
In the last 3 years, LIVN stock traded as high as $93.89 and as low as $40.26.
The top ETF exchange traded funds that LIVN belongs to (by Net Assets): IJH, IWM, VXF, IWN, MDY.
LIVN stock has underperformed the market in the last year with a return of +15.8%, while SPY returned +26.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in LIVN shares. However, LIVN has outperformed the market in the last 3 month and 2 week periods, returning +11.2% and +2.7%, while SPY returned +4.5% and -1.9%, respectively. This indicates LIVN has been having a stronger performance recently.
LIVN support price is $54.03 and resistance is $56.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIVN stock will trade within this expected range on the day.